The largest database of trusted experimental protocols

Pgl4.32 luc2p nf κb re hygro luciferase reporter vector

Manufactured by Promega
Sourced in United States

The PGL4.32[luc2P/NF-κB-RE/Hygro] luciferase reporter vector contains the firefly luciferase gene luc2P under the control of a minimal promoter element and tandem NF-κB response elements. The vector also includes a hygromycin resistance gene for selection in mammalian cells.

Automatically generated - may contain errors

4 protocols using pgl4.32 luc2p nf κb re hygro luciferase reporter vector

1

NF-κB Activation Assay in RAW264.7 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pGL4.32 [luc2P/NF-κB-RE/Hygro] luciferase reporter vector (Promega, Madison, WI) was electroporated into RAW264.7 cells by using a Lonza Nucleofector II instrument (Amaxa Biosystems, Germany) as described previously [18 (link)]. Cells were incubated with pinocembrin (0–150 µM) for 2 h and followed by an additional treatment with LPS (1 μg/ml) for 22 h. Cells were washed with PBS and then lysed in 1× passive lysis buffer (100 µl). The luciferase activity from cell lysates was detected using a luciferase assay system (Promega, Madison, WI). Results were expressed as fold induction of control cells.
+ Open protocol
+ Expand
2

NF-κB Transcriptional Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
2×106 LS174T cells in 100 μl transfection buffer (Cell Line Nucleofector Kit V) were co-electroporated with 1 μg pGL4.32[luc2P/NF-κB-RE/Hygro] luciferase reporter vector (Promega, Madison, WI), 0.5 μg expression vector (pSG5-hPXR or pSG5 control), and 0.1 μg pRL-TK vector using Lonza Nucleofector II instrument (program Q-009). For detailed plasmids information, please refer to our previous report (Dou et al., 2012a (link)). The cells were transferred to 48-well plate following transfection and were treated with TNF-α (20 ng/ml, Sigma-Aldrich, St. Louis, MO) alone or in combination with alpinetin (25 μM) for 24 h. The cells were harvested in passive lysis buffer (Promega) and luciferase activity was detected using the dual-luciferase reporter assay system (Promega). Luminescence was detected by Turner Bio-systems Luminometer 20/20n (Turner Biosystems, CA). The results were expressed as the fold induction of the control cells.
+ Open protocol
+ Expand
3

NF-κB Luciferase Reporter Assay with ALA and LPS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pGL4.32[luc2P/NF-κB-RE/Hygro] luciferase reporter vector (Promega, Madison, WI) was electroporated into LS174T cells or HT-29 cells. The pGL4.32 reporter is a NF-κB reporter vector including NF-κB response elements and firefly luciferase gene. Cells were incubated with ALA (0–25 µM) for 2 h followed by an additional co-incubation with lipopolysaccharide (LPS, 1 µg/ml) for 24 h. The luciferase activity was detected using a luciferase assay system (Promega, Madison, WI).
+ Open protocol
+ Expand
4

Regulation of B7-H3 in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
RPMI 1640 medium, DMEM (Dulbecco’s Modified Eagle Medium), fetal bovine serum (FBS), and a 0.02% ethylenediaminetetraacetic acid (EDTA) solution were obtained from Invitrogen (Gibco BRL, Grand Island, NY, USA). The human B7-H3 antibody, recombinant human B7-H3 protein, human B7-H3 ELISA kit, and the IL-8 and VEGF immunoassay ELISA kits were purchased from R&D Systems (Minneapolis, MN, USA). The PGL4.32 (Luc2p/NF-κB-RE/Hygro) luciferase reporter vector, the PRL-TK vector dual-luciferase reporter assay system and the FuGENE 6 Transfection Reagent were purchased from Promega (Madison, WI, USA). The anti-TLR4 and anti-NF-κB p65 antibodies were obtained from Abcam (Cambridge, UK), the NF-kB inhibitor BAY11-7028 was obtained from Sigma (St. Louis, MO, USA), and the TLR4 inhibitor TAK-242 was purchased from InvivoGen (San Diego, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!